Automated description from the Alliance of Genome Resources (Release 7.1.0)
Predicted to enable alpha-N-acetylgalactosaminidase activity; alpha-galactosidase activity; and protein homodimerization activity. Predicted to be involved in several processes, including glycolipid catabolic process; glycoside catabolic process; and oligosaccharide metabolic process. Predicted to act upstream of or within lipid metabolic process. Predicted to be located in lysosome. Predicted to be active in cytoplasm. Is expressed in nervous system and skeleton. Human ortholog(s) of this gene implicated in Kanzaki disease; Schindler disease type 1; angiokeratoma; and neuroaxonal dystrophy. Orthologous to human NAGA (alpha-N-acetylgalactosaminidase).